MarketSmith has a positive view on several stocks it considers near their buy points. These stocks include Shriram Finance, Bharti Airtel, and Hindalco. Here is a list of 7 stocks that are near their buy points, as listed on MarketSmith:
Getty Images
2/8
Shriram Finance | CMP: Rs 680
With an operating revenue of Rs 40,297 crore on a trailing 12-month basis, Shriram Finance has reported an outstanding annual revenue growth of 19%, a pre-tax margin of 27%, and an ROE of 15%.
The stock is comfortably placed above its key moving averages, approximately 17% and 11% above the 50DMA and 200DMA, respectively. It has recently broken out of a base on its weekly chart and is trading around 3% from the pivot point (the ideal buying range).
Agencies
3/8
Bharti Airtel | CMP: Rs 1,720
Bharti Airtel has an operating revenue of Rs 1,62,708 crore on a trailing 12-month basis. The company has annual revenue growth of 8%, a pre-tax margin of 7%, and an ROE of 7%. However, the company has a high debt-to-equity ratio of 130%, which may be a concern.
Technically, the stock is comfortably above its key moving averages, around 5% and 9% from the 50-DMA and 200-DMA, respectively. It is currently forming a base on its weekly chart and is trading around 2% away from the crucial pivot point.
Reuters
4/8
Associated Alcohols & Breweries | CMP: Rs 1,402
Associated Alcohols & Breweries has an operating revenue of Rs 1,075 crore on a trailing 12-month basis. The company has an annual revenue growth of 8%, a pre-tax margin of 9%, and an ROE of 11%. The company has a reasonable debt-to-equity ratio of 12%, indicating a healthy balance sheet.
The stock is comfortably placed above its key moving averages, approximately 16% and 47% above the 50-DMA and 200-DMA, respectively. It is currently forming a base on its weekly chart and is trading around 4% from the crucial pivot point.
etimes.in
5/8
Hindalco Industries | CMP: Rs 701
Hindalco Industries has an operating revenue of Rs 2,29,600 crore on a trailing 12-month basis. The company has a revenue de-growth of -3%, a pre-tax margin of 6%, and an ROE of 9%. The company has a reasonable debt-to-equity ratio of 45%, signaling a healthy balance sheet.
Technically, the stock is comfortably placed above its key moving averages, around 11% and 5% above the 50-DMA and 200-DMA, respectively. It has recently broken out of a base on its weekly chart and is trading around -1% from the pivot point (the ideal buying range).
IANS
6/8
India Shelter Finance | CMP: Rs 796
India Shelter Finance has an operating revenue of Rs 1,073 crore on a trailing 12-month basis. The company has annual revenue growth of 42%, a pre-tax margin of 38%, and an ROE of 10%.
The stock is comfortably placed above its key moving averages, around 13% and 11% above the 50-DMA and 200-DMA, respectively. It has recently broken out of a base on its weekly chart and is trading around -1% from the pivot point (the ideal buying range).
ETMarkets.com
7/8
Blue Star | CMP: Rs 2,212
Blue Star has an operating revenue of Rs 11,276 crore on a trailing 12-month basis. The company has outstanding annual revenue growth of 22%, a pre-tax margin of 6%, and an ROE of 15%. The company is debt-free and has a strong balance sheet, enabling it to report stable earnings growth across business cycles.
Technically, the stock is comfortably placed above its key moving averages, around 9% and 14% above the 50-DMA and 200-DMA, respectively. It has recently broken out of a base on its weekly chart and is trading around -2% from the pivot point (the ideal buying range).
ETMarkets.com
8/8
AstraZeneca Pharma India | CMP: Rs 8,440
AstraZeneca Pharma India has an operating revenue of Rs 1,619 crore on a trailing 12-month basis. The company has outstanding annual revenue growth of 29%, a pre-tax margin of 27%, and an ROE of 22%. The company is debt-free and has a strong balance sheet, enabling it to report stable earnings growth across business cycles.
The stock is comfortably placed above its key moving averages, around 16% and 22% above the 50DMA and 200DMA, respectively. It has recently broken out of a base on its weekly chart and is trading around 4% from the pivot point (the ideal buying range).
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)